Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

Updated April 9th, 2020

Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

An impurity in the ingredient ranitidine has been found to increase cancer-risk over time. Find out what over-the-counter heartburn remedies you can safely take instead:

NOW
PLAYING
New Research Says No Significant Increased Risk Of Death In COVID-19 Patients With Cancer; Here's What To Know
NOW
PLAYING
What Should Blood Cancer Patients Do After They Get the COVID-19 Vaccine?
NOW
PLAYING
Do Medications to Treat High Blood Pressure Cause Cancer? A New Mega-Study Offers Answers
NOW
PLAYING
New York Legalizes Recreational Marijuana; What You Need to Know about Marijuana and Cancer
NOW
PLAYING
Which Vaccine is Best For Cancer Patients? 'The First One Available to You' Say Leading Experts
NOW
PLAYING
Remember When Comedian Kathy Griffin Got a Pap Smear on TV? Did This Impact Cervical Cancer Screenings?

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.